Goldman Sachs Reinstates "Buy" Rating on XIAOMI-W (01810) and Raises Target Price to 63 Hong Kong Dollars
The bank believes that last year was just the beginning of Xiaomi's years of growth trajectory, mainly benefiting from the expansion of its "person-vehicle-home" ecosystem, increased investment in six core strategies, and improved attractiveness to global consumer brands.
Goldman Sachs released a research report stating that it maintains a "buy" rating on XIAOMI-W (01810), with a target price raised from HK$58 to HK$63. The average revenue forecast for Xiaomi for the fiscal years 2025-2027 has been adjusted upwards by 3%, and the adjusted net profit forecast has been raised by 9%.
Goldman Sachs pointed out that Xiaomi Group's fourth-quarter performance in the fiscal year 2024 continued to exceed expectations. During the period, revenue increased by 49% year-on-year, higher than the bank's and market's expectations by 3% and 6%, respectively; adjusted net profit increased by 70% year-on-year, surpassing the bank's and market's expectations by 26% and 32%. The bank believes that last year was just the beginning of Xiaomi's multi-year growth trajectory, mainly benefiting from the expansion of its "person, car, and home" ecosystem, increased investment in six core strategies, and the enhancement of its global consumer brand appeal. The bank believes that Xiaomi's challenges at the Nurburgring racetrack with the "SU7 Ultra," the 15th anniversary product release event, and the Shanghai Auto Show in April-May are all potential catalysts for Xiaomi's future stock price.
Related Articles

ST Holdings (08305) issued a profit warning, expecting the comprehensive loss for the year 2025 to increase by no less than 19 million Hong Kong dollars compared to the previous year.

CLOVER BIO-B(02197): Clover Hong Kong has entered into a settlement agreement with the Global Vaccine Immunization Alliance.

NEW GONOW RV (00805) is expected to have a net profit of approximately 31 to 40 million yuan in the fiscal year 2025, a year-on-year decrease of about 12.07% to 31.85%.
ST Holdings (08305) issued a profit warning, expecting the comprehensive loss for the year 2025 to increase by no less than 19 million Hong Kong dollars compared to the previous year.

CLOVER BIO-B(02197): Clover Hong Kong has entered into a settlement agreement with the Global Vaccine Immunization Alliance.

NEW GONOW RV (00805) is expected to have a net profit of approximately 31 to 40 million yuan in the fiscal year 2025, a year-on-year decrease of about 12.07% to 31.85%.

RECOMMEND

State Reform Fund And Three Major Banks Backstop Voyah As It Secures Hong Kong’s First Auto IPO This Year
20/03/2026

Hong Kong IPO Irregularities Surface As Corner Placements And Retail Losses Emerge, Haizhi Technology Implicated
20/03/2026

Gold And Silver Experience Sharp Sell‑Off As Global Rate‑Hike Expectations Intensify
20/03/2026


